Pharmacopeia
Master Compare
Compare candidate-facing canonical Pharmacopeia fields side by side. Isolated AI-draft proposals are never included.
| Field |
AZOLES
Anti-infectives · Anti-infectives
|
CASPOFUNGIN
Anti-infectives · Anti-infectives · Level 3
|
|---|---|---|
| Mechanism of action | Azoles disrupt ergosterol production by interacting with 14-alpha demthylase, a cytochrome P450 enzyme necessary to convert lanosterol to ergosterol. As ergosterol is an essential component of fungal cell membranes, inhibition of its synthesis leads to increased cell permeability causing leakage of contents. |
— |
| Absorption | Well absorbed orally (except miconazole) |
— |
| Distribution | Fluc – good CSF penetration |
— |
| Protein binding | Itra, Keto – 99% PB |
— |
| Metabolism | Fluc not metabolized well |
— |
| Excretion | Fluc – Urine unchanged |
— |
| Adverse Effects Toxicity | Fluc: N/V/D, Abdominal pain |
— |
| Antimicrobial Spectrum | Fluc: Candida |
— |
| Class Group | Antifungal |
Antifungal |
| Introduction | Triazoles: Fluconazole, Itraconazole, Voriconazole, Posaconazole |
— |
| Legacy Cicm Level | Level 3 |
Level 3 |
| Resistance Mechanism | Fluc: Some candida species, Decreased drug concentration |
— |
| Special Points | potent CYP inhibitors with a wide range of drug interactions (including warfarin) |
— |